JULIO ORTIZ: Open Payments
NPI 1831890995 · CALEXICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 22 payments from 11 companies in 2025. Trend: 2023 $145 · 2024 $593 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $242 |
| Alnylam Pharmaceuticals Inc. | 2 | $62 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| CeQur Corporation | 1 | $31 |
| Amgen Inc. | 2 | $30 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $26 |
| Corcept Therapeutics | 1 | $25 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
Products named: AIRSUPRA, BREZTRI, GIVLAARI, GEMTESA, CeQur Simplicity, ISTURISA, Korlym, ACCRUFER.
Industry payments across CA — which companies pay providers there.
